Talk:Jeffrey Bluestone

This article must adhere to the biographies of living persons (BLP) policy, even if it is not a biography, because it contains material about living persons. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard.

If you are a subject of this article, or acting on behalf of one, and you need help, please see this help page.

Biography: Science and Academia

	Biography portal This article is within the scope of WikiProject Biography, a collaborative effort to create, develop and organize Wikipedia's articles about people. All interested editors are invited to join the project and contribute to the discussion. For instructions on how to use this banner, please refer to the documentation.BiographyWikipedia:WikiProject BiographyTemplate:WikiProject Biographybiography articles
	This article is supported by the science and academia work group.

Jeff Bluestone Title EditTheodorajulienne (talk) 17:36, 16 August 2022 (UTC)[edit]

Part of an edit requested by an editor with a conflict of interest has been implemented.

"Jeffrey Bluestone is the A.W. and Mary Margaret Clausen Distinguished Professor of Metabolism and Endocrinology and the director of the Hormone Research Institute in the Diabetes Center at the University of California, San Francisco" should be "Jeffrey Bluestone is the Chief Executive Officer and President of Sonoma Biotherapeutics, an immune tolerance company developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system.

Please add "He was the A.W. and Mary Margaret Clausen Distinguished Professor of Metabolism and Endocrinology and the director of the Hormone Research Institute in the Diabetes Center at the University of California, San Francisco, and was, for a number of years, an earlier executive vice chancellor and provost of that university."

Please remove "As of April 2016, he was also serving as the president and CEO of the Parker Institute for Cancer Immunotherapy." — Preceding unsigned comment added by Theodorajulienne (talk • contribs) 23:30, 21 August 2022 (UTC)[reply]

Please see here for sources to support these claims: https://www.biopharmadive.com/news/treg-cell-therapy-biotech-startups/629634/ https://www.bizjournals.com/sanfrancisco/news/2020/02/06/jeff-bluestone-sean-parker-sonoma-biotherapeutics.html https://www.statnews.com/2020/02/06/jeffrey-bluestone-sonoma/ https://endpts.com/jeffrey-bluestone-exits-parker-and-switches-focus-back-to-autoimmune-diseases-in-cell-therapy-2-0-launch/ https://www.sonomabio.com/team/jeff-bluestone-2 Theodorajulienne (talk) 17:36, 16 August 2022 (UTC)[reply]

Partly done: I added that he's CEO of SB without the advertorial flair. Did not remove either the professorship, nor the Parker Institute historical reference (his university bio still lists him as Professor), and there is no reason why his stint at Parker should be deleted. PK650 (talk) 03:28, 31 August 2022 (UTC)[reply]